BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 4154028)

  • 21. Rigidity, hyperpyrexia and coma following fluphenazine enanthate.
    Meltzer HY
    Psychopharmacologia; 1973; 29(4):337-46. PubMed ID: 4707025
    [No Abstract]   [Full Text] [Related]  

  • 22. Experience of psychiatric management of schizophrenia with fluphenazine decanoate.
    Grosser HH
    Dis Nerv Syst; 1970 Sep; 31():Suppl:32-6. PubMed ID: 4920312
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of fluphenazine enanthate in an out-patient clinic.
    Kingstone E
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):413-6. PubMed ID: 4882607
    [No Abstract]   [Full Text] [Related]  

  • 24. Dyskinesia and neuroleptics.
    Crane GE
    Arch Gen Psychiatry; 1968 Dec; 19(6):700-3. PubMed ID: 5697636
    [No Abstract]   [Full Text] [Related]  

  • 25. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of haloperidol in drug refractory patients.
    Ban TA; Lehmann HE
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:78-86. PubMed ID: 4383142
    [No Abstract]   [Full Text] [Related]  

  • 27. Dosage and side effect comparisons betweel oral and depot fluphenazine.
    Schooler NR; Levine J
    Psychopharmacol Bull; 1977 Jul; 13(3):29-31. PubMed ID: 329328
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-acting therapy of schizophrenia.
    Rapisarda V; Bonomo V; Parisi R
    Adv Biochem Psychopharmacol; 1985; 40():25-8. PubMed ID: 4025038
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluphenazine enanthate in the outpatient treatment of late paraphrenia.
    Raskind M; Alvarez C; Herlin S
    J Am Geriatr Soc; 1979 Oct; 27(10):459-63. PubMed ID: 469146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind comparison of fluphenazine and haloperidol in outpatient schizophrenic children.
    Engelhardt DM; Polizos P; Waizer J; Hoffman SP
    J Autism Child Schizophr; 1973; 3(2):128-37. PubMed ID: 4583792
    [No Abstract]   [Full Text] [Related]  

  • 31. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB; Vestre ND; Schiele BC; Zimmermann R
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-acting neuroleptic preparations and their use in mental disorders].
    Vovin RIa; Vovina EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):920-4. PubMed ID: 5050052
    [No Abstract]   [Full Text] [Related]  

  • 33. Maintenance therapy and schizophrenia.
    Leff JP
    Br J Psychiatry; 1975; Spec No 9():55-8. PubMed ID: 241453
    [No Abstract]   [Full Text] [Related]  

  • 34. Outpatient treatment of psychotic patients with a long-acting phenothiazine: fluphenazine decanoate.
    Kinzie JD; Simons RC
    Med J Malaya; 1971 Dec; 26(2):129-32. PubMed ID: 4260859
    [No Abstract]   [Full Text] [Related]  

  • 35. The depot fluphenazines: a reappraisal after 10 years' clinical experience.
    Ayd FJ
    Am J Psychiatry; 1975 May; 132(5):491-500. PubMed ID: 1091162
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood serum concentration of long-acting fluphenazine in patients with various forms of schizophrenia].
    Pempkowiak L; Januszkiewicz-Grabiasowa A; Góra S
    Psychiatr Pol; 1979; 13(1):1-8. PubMed ID: 419224
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation.
    DeWolfe AS; Barrell RP; London L; Spaner FE
    Psychosomatics; 1971; 12(3):186-90. PubMed ID: 4950862
    [No Abstract]   [Full Text] [Related]  

  • 38. [Trial at the guidance center of ixelles of a major neuroleptic drug: anatensol decanoate].
    Berliner J
    Acta Psychiatr Belg; 1974 May; 74(3):305-16. PubMed ID: 4455024
    [No Abstract]   [Full Text] [Related]  

  • 39. Fluphenazine enanthate in sesame oil, a depot preparation.
    Rasmussen OS
    Acta Psychiatr Scand; 1970; 46(3):311-8. PubMed ID: 5490593
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of long-acting fluphenazine].
    Marcjan K; Pietruszewska I; Wolak E
    Psychiatr Pol; 1973; 7(1):79-86. PubMed ID: 4715837
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.